Jeffrey A. Clanton, M.S.

Associate in
Faculty Appointments
Associate in Radiology and Radiological Sciences
M.S., University of Southern California, Los Angeles, CaliforniaB.S., Samford University, Birmingham, Alabama
Office Address
Dept. of Radiology and Radiological Sciences
MRB1, Room 1251
Nashville, TN 37232-2675
Research Description
Manager, Cyclotron Facility:
Manage cyclotron facility for clinical and research use as well as repair and maintenance.
Clinical Description
Director of Radiopharmacy Services;
Mange the production and distribution of all radiopharmaceuticals in the Vanderbilt network. This includes in-house compounding and research radiopharmaceuticals.
Research Keywords
Cyclotron, PET radiotracers
Clinical Research Keywords
Radiopharmaceutical, Ga-68
Deppen SA, Liu E, Blume JD, Clanton J, Shi C, Jones-Jackson LB, Lakhani V, Baum RP, Berlin J, Smith GT, Graham M, Sandler MP, Delbeke D, Walker RC. Safety and Efficacy of 68Ga-DOTATATE PET/CT for Diagnosis, Staging, and Treatment Management of Neuroendocrine Tumors. J. Nucl. Med [print-electronic]. 2016 May; 57(5): 708-14. PMID: 26769865, PII: jnumed.115.163865, DOI: 10.2967/jnumed.115.163865, ISSN: 1535-5667.

Drozdovitch V, Brill AB, Callahan RJ, Clanton JA, DePietro A, Goldsmith SJ, Greenspan BS, Gross MD, Hays MT, Moore SC, Ponto JA, Shreeve WW, Melo DR, Linet MS, Simon SL. Use of radiopharmaceuticals in diagnostic nuclear medicine in the United States: 1960-2010. Health Phys. 2015 May; 108(5): 520-37. PMID: 25811150, PMCID: PMC4376015, PII: 00004032-201505000-00005, DOI: 10.1097/HP.0000000000000261, ISSN: 1538-5159.

Walker RC, Smith GT, Liu E, Moore B, Clanton J, Stabin M. Measured human dosimetry of 68Ga-DOTATATE. J. Nucl. Med [print-electronic]. 2013 Jun; 54(6): 855-60. PMID: 23516312, PMCID: PMC4472480, PII: jnumed.112.114165, DOI: 10.2967/jnumed.112.114165, ISSN: 1535-5667.

Hallahan D, Geng L, Qu S, Scarfone C, Giorgio T, Donnelly E, Gao X, Clanton J. Integrin-mediated targeting of drug delivery to irradiated tumor blood vessels. Cancer Cell. 2003 Jan; 3(1): 63-74. PMID: 12559176, PII: S1535610802002386, ISSN: 1535-6108.

Abernathy VJ, Pou NA, Wilson TL, Parker RE, Mason SN, Clanton JA, Baudendistel LJ, Roselli RJ. Noninvasive measures of radiolabeled dextran transport in in situ rabbit lung. J. Nucl. Med. 1995 Aug; 36(8): 1436-41. PMID: 7543146, ISSN: 0161-5505.

Votaw JR, Ansari MS, Mason NS, Schmidt D, de Paulis T, Holburn G, Clanton JA, Votaw DB, Manning RG, Kessler RM. Dosimetry of iodine-123-epidepride: a dopamine D2 receptor ligand. J. Nucl. Med. 1995 Jul; 36(7): 1316-21. PMID: 7790962, ISSN: 0161-5505.

Kessler RM, Whetsell WO, Ansari MS, Votaw JR, de Paulis T, Clanton JA, Schmidt DE, Mason NS, Manning RG. Identification of extrastriatal dopamine D2 receptors in post mortem human brain with [125I]epidepride. Brain Res. 1993 Apr 4/23/1993; 609(1-2): 237-43. PMID: 8099521, ISSN: 0006-8993.

Kessler RM, Votaw JR, Schmidt DE, Ansari MS, Holdeman KP, de Paulis T, Clanton JA, Pfeffer R, Manning RG, Ebert MH. High affinity dopamine D2 receptor radioligands. 3. [123I] and [125I]epidepride: in vivo studies in rhesus monkey brain and comparison with in vitro pharmacokinetics in rat brain. Life Sci. 1993; 53(3): 241-50. PMID: 8321085, ISSN: 0024-3205.

Kessler RM, Mason NS, Votaw JR, De Paulis T, Clanton JA, Ansari MS, Schmidt DE, Manning RG, Bell RL. Visualization of extrastriatal dopamine D2 receptors in the human brain. Eur. J. Pharmacol. 1992 Nov 11/13/1992; 223(1): 105-7. PMID: 1478255, PII: 0014-2999(92)90825-O, ISSN: 0014-2999.

Kessler RM, Ansari MS, de Paulis T, Schmidt DE, Clanton JA, Smith HE, Manning RG, Gillespie D, Ebert MH. High affinity dopamine D2 receptor radioligands. 1. Regional rat brain distribution of iodinated benzamides. J. Nucl. Med. 1991 Aug; 32(8): 1593-600. PMID: 1831229, ISSN: 0161-5505.

Kessler RM, Ansari MS, Schmidt DE, de Paulis T, Clanton JA, Innis R, al-Tikriti M, Manning RG, Gillespie D. High affinity dopamine D2 receptor radioligands. 2. [125I]epidepride, a potent and specific radioligand for the characterization of striatal and extrastriatal dopamine D2 receptors. Life Sci. 1991; 49(8): 617-28. PMID: 1830917, ISSN: 0024-3205.

Pou NA, Roselli RJ, Parker RE, Clanton JA, Harris TR. Measurement of lung fluid volumes and albumin exclusion in sheep. J. Appl. Physiol. 1989 Oct; 67(4): 1323-30. PMID: 2793731, ISSN: 8750-7587.

de Paulis T, Janowsky A, Kessler RM, Clanton JA, Smith HE. (S)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-5-[125I]iodo- 2-methoxybenzamide hydrochloride, a new selective radioligand for dopamine D-2 receptors. J. Med. Chem. 1988 Oct; 31(10): 2027-33. PMID: 3172140, ISSN: 0022-2623.

Whelan HT, Clanton JA, Wilson RE, Tulipan NB. Comparison of CT and MRI brain tumor imaging using a canine glioma model. Pediatr. Neurol. 1988 Sep; 4(5): 279-83. PMID: 3242530, ISSN: 0887-8994.

Janowsky A, De Paulis T, Clanton JA, Smith HE, Ebert MH, Kessler RM. [125I]iodopride: a specific high affinity radioligand for labelling striatal dopamine D-2 receptors. Eur. J. Pharmacol. 1988 May 5/20/1988; 150(1-2): 203-5. PMID: 3402540, PII: 0014-2999(88)90772-8, ISSN: 0014-2999.

O'Day DM, Head WS, Robinson RD, Clanton JA. Bioavailability and penetration of topical amphotericin B in the anterior segment of the rabbit eye. J Ocul Pharmacol. 1986; 2(4): 371-8. PMID: 3503121, ISSN: 8756-3320.

Runge VM, Clanton JA, Price AC, Wehr CJ, Herzer WA, Partain CL, James AE. The use of Gd DTPA as a perfusion agent and marker of blood-brain barrier disruption. Magn Reson Imaging. 1985; 3(1): 43-55. PMID: 3923292, ISSN: 0730-725X.

Runge VM, Clanton JA, Price AC, Herzer WA, Wehr CJ, Lukehart CM, Partain CL, James AE. Paramagnetic contrast agents in magnetic resonance imaging: research at Vanderbilt University. Physiol Chem Phys Med NMR. 1984; 16(2): 113-22. PMID: 6438656, ISSN: 0748-6642.

Runge VM, Clanton JA, Lukehart CM, Partain CL, James AE. Paramagnetic agents for contrast-enhanced NMR imaging: a review. AJR Am J Roentgenol. 1983 Dec; 141(6): 1209-15. PMID: 6606318, DOI: 10.2214/ajr.141.6.1209, ISSN: 0361-803X.